Steven Quay, MD, PhD

Steven Quay, MD, PhD is the founder of Seattle-based Atossa Therapeutics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer.

He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 12,000 times, placing him in the top 1% of scientists worldwide. He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 91 US patents. Over 80 million people have benefited from the medicines he invented.

His current passion is the prevention of the two million yearly breast cancer cases worldwide.